secwatch / observer
8-K filed November 27, 2023, 6:59 PM ET ticker ZIVO CIK 0001101026
regulatory confidence high sentiment negative materiality 0.85

Zivo Bioscience, Inc. (ZIVO): Nasdaq/NYSE listing notice — ZIVO Bioscience receives Nasdaq delisting notice; shares to trade on OTC Pink Sheets

Zivo Bioscience, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Zivo Bioscience, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange
nasdaq
Notice
delisting notice
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
November 22, 2023, the Company was notified by The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of the Company’s previously disclosed noncompliance with Nasdaq Listing Rule 5550(b)(1), Nasdaq has determined to delist the Company’s common stock from the Nasdaq Capital Market and, accordingly, will suspend trading in the Company’s common stock effective at the open of business, on November 27, 2023. Nasdaq further indicated that it will file a Form 25 Notification of Delisting with the Securities and Exchange Commission (the “ SEC ”). The Company has applied to have its common stock quo
View on SEC.gov

Browse all listing & compliance notices →

Zivo Bioscience, Inc. filing history →

Source: SEC EDGAR
accession 0001654954-23-014775
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.